Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Atea Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 107 | 1 | 104 | −2 |
| Shares | 56.3M | 291.1K | 52.9M | −3.10M (−5.5%) |
| Value | $188.7M | $975.2K | $158.3M | −$29.4M (−15.7%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 291,091 | $870.4K | 0.00% |
| Deutsche Bank AG | 60,263 | $180.2K | 0.00% |
| Aldebaran Capital, LLC | 37,500 | $112.1K | 0.11% |
| Oxford Asset Management LLP | 22,202 | $66.4K | 0.03% |
| CIBC World Markets Corp | 17,122 | $51.2K | 0.00% |
| US Bancorp | 6,010 | $18.0K | 0.00% |
| FNY Investment Advisers, LLC | 5,000 | $14.0K | 0.01% |
| Coldstream Capital Management Inc | 3,188 | $9.53K | 0.00% |
| EverSource Wealth Advisors, LLC | 116 | $347 | 0.00% |
Sold out (11)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| EcoR1 Capital, LLC | 3,341,653 | $11.2M |
| ADAR1 Capital Management, LLC | 110,000 | $368.5K |
| Marshall Wace, LLP | 77,581 | $259.9K |
| Verition Fund Management LLC | 67,304 | $225.5K |
| Marquette Asset Management, LLC | 47,166 | $158.0K |
| Zacks Investment Management | 13,966 | $46.8K |
| ExodusPoint Capital Management, LP | 13,817 | $46.0K |
| Leonteq Securities AG | 5,000 | $16.8K |
| Simplex Trading, LLC | 3,426 | $11.0K |
| Meeder Asset Management Inc | 1,584 | $5.31K |
| Caitong International Asset Management Co., Ltd | 479 | $1.60K |
Not filed for Q1 2025 yet (1)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 291,091 | $975.2K |